This advanced, image-guided femtosecond laser platform is designed to transform the treatment of glaucoma. Built on decades of proven laser technology, it enables surgeons to perform highly precise, non-invasive interventions with exceptional control and confidence.

At the core of the system is the proprietary FLigHT procedure, which creates a precise drainage channel in the trabecular meshwork to improve aqueous outflow without opening the eye. This approach minimises trauma to surrounding tissue while enhancing safety, predictability and patient recovery.

The platform integrates three key technologies. The ViaVue™ Gonio Camera provides high-definition visualisation. The ViaLens™ Patient Interface ensures stable and controlled delivery. The laser enables micron-accurate treatment. Together, these components deliver consistent visualisation and precision throughout every stage of the procedure.

Backed by first-in-human clinical data, the system has demonstrated sustained intraocular pressure reduction with no serious treatment-related adverse events over 24 months. These results support its potential to redefine glaucoma management.